Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials-Reference-Cited by-同舟云学术

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Published:2014-03 Issue:9921 Volume:383 Page:955-962
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Ruff Christian T,Giugliano Robert P,Braunwald Eugene,Hoffman Elaine B,Deenadayalu Naveen,Ezekowitz Michael D,Camm A John,Weitz Jeffrey I,Lewis Basil S,Parkhomenko Alexander,Yamashita Takeshi,Antman Elliott M

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC);Camm;Eur Heart J,2010

2. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation;Hylek;N Engl J Med,2003

3. Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation;Birman-Deych;Stroke,2006

4. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation;Hylek;Circulation,2007

5. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

Cited by 4086 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial fibrillation management in older hospitalized patients: Evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry;Archives of Gerontology and Geriatrics;2025-01

2. La fibrillation atriale à l'Hôpital Principal de Dakar au Sénégal : résultats et limites de la prise en charge;Annales de Cardiologie et d'Angéiologie;2024-12

3. Assessing mortality and safety of IV thrombolysis in ischemic stroke patients on direct oral anticoagulants (DOACs): A systematic review and meta-analysis;Clinical Neurology and Neurosurgery;2024-11

4. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design;American Heart Journal;2024-11

5. Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention;Interventional Cardiology Clinics;2024-10